- Home
- Plastic Surgery
- Aesthetic Surgery
- augmentation mammoplasty
- Breast implant removals
- Mastopexy
- Buttock lift
- Jaw reshaping
- Dermabrasion
- Blepharoplasty
- Rhytidectomy
- Forehead lift
- Hair Transplantation
- Lip augmentation
- Lipoplasty
- Lower body lift
- Rhinoplasty
- Thigh lift
- Abdominoplasty
- Brachioplasty
- Botox injections
- Cellulite treatment
- Chemical peel
- Facial rejuvenation
- Laser skin resurfacing
- Laser treatment of leg veins
- Vaginal rejuvenation
- Aesthetic Surgery
- Dentistry (Odontology)
- Miami fashion
- Real estate
- Entertainment
- lifestyle
Subscribe to Updates
Browsing: FDA
Establishment Labs is submitting to the FDA for approval of Motiva implants for breast reconstruction
NEW YORK, December 29, 2025–(BUSINESS WIRE)–Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, primarily in breast…
Two groups apply to the FDA for the prohibition of mercury dental filling, reflecting EU movement
(Istock) Two groups – the International Academy of Oral Medicine and Toxicology (IAOMT) and Amalgama Mercury Solutions (Dams Inc.) – have submitted a report prompting US…
Salt Lake City (Ktvx) – on May 7, a The law prohibiting fluoride in Utah’s public drinking water came into force. Less than a week later,…
Facebook Tweet E-mail Link The US Food and Drug Administration says it is starting the process of abolishing fluoride prescription tablets and market drops. These products…
FDA is moving to ban fluoride supplements for children by removing a basic tool for dentists: shots
Dentists sometimes prescribe fluoride supplements in children in areas that do not have water fluorization. The FDA is taking action to remove such market therapies. Karl…
FDA clearance supported by extremely urgent clinical study results that prove that 93% of the issues undergoing “improved” or “much improved” appearance after treatment using Superb…
The Food and Drug Administration (FDA) approved the Journavx ™ (Suzetrigine) to treat measure to severe acid pain in adults. The active ingredient in Journavx is…
According to a new announcement, the FDA approved Suzetrigine (Vertex Pharmaceuticals), an oral selective NAV1.8 inhibitor, to treat patients with moderate to severe acute pain. Advertised…
New resin Eliminates >99.9% of bacteria and fungi in vitro that lead to stomatitis from biofilms and dentures in 3D printed dentures NEWPORT BEACH, Calif., October…
An announcement was made by Accure Acne, Inc., a company known for its acne treatment solutions, that they received Clearance K242035 from the US Food and…